Medtronic's ABRE Venous Stent Study Meets Safety and Effectiveness Endpoints; 12-Month Data Presented
June 16, 2020—Twelve-month data from Medtronic's ABRE pivotal, investigational device exemption, venous stent study were presented by Stephen Black, MD, during a Charing Cross (CX) 2020 virtual session dedicated to deep venous disease.
Infinity Angioplasty Balloon Catheter Receives 510(k) Clearance
June 16, 2020—Infinity Angioplasty Balloon Co., LLC announced that the FDA has cleared the Infinity angioplasty balloon catheter for percutaneous transluminal angioplasty treatment of peripheral arterial disease in the peripheral vasculature, including iliac, femoral, popliteal, and infrapopliteal arteries, and for the treatment of arteriovenous dialysis fistulas.
BD Launches Halo One Thin-Walled Guiding Sheath
June 5, 2020—BD (Becton, Dickinson and Company) announced the launch of the Halo One thin-walled guiding sheath, which is designed to perform as both a guiding sheath and an introducer sheath for use in peripheral artery and venous procedures requiring percutaneous introduction of intravascular devices.
FDA Issues Emergency Use Authorization for Impella RP as Therapy for COVID-19 Patients With Right Heart Failure
June 1, 2020—Abiomed announced that the FDA has issued an emergency use authorization (EUA) for the company’s Impella RP to include patients with COVID-19–related right heart failure or decompensation, including pulmonary embolism (PE).
COVID-19 Shown to Cause Severe Vascular Damage by Invading Endothelial Cells
May 21, 2020—The Angiogenesis Foundation announced the publication of new research showing that the respiratory virus SARS-CoV-2, which causes COVID-19, causes severe damage to blood vessels, leading to widespread thrombosis in the lung.
Mount Sinai Study Finds Anticoagulants May Improve Survival in Hospitalized COVID-19 Patients
May 6, 2020—The Mount Sinai Hospital and Icahn School of Medicine at Mount Sinai in New York, New York, announced the publication of a research letter from the Mount Sinai COVID Informatics Center reporting that treating hospitalized COVID-19 patients with anticoagulants may improve their chances of survival.
Algorithm for Practical Diagnosis and Treatment of Suspected VTE During COVID-19 Pandemic Proposed
May 1, 2020—The Society for Vascular Surgery announced the publication of an evidence-based algorithm espousing empiric treatment for venous thromboembolism (VTE) without confirmatory imaging during the COVID-19 pandemic.
PERT Consortium Announces COVID-19 PE Registry
April 28, 2020—The Pulmonary Embolism Response Team (PERT) Consortium announced the new PERT COVID-19 PE Registry, which is intended to be a de-identified, observational registry within an existing large multi-institutional database dedicated to the study of patients with pulmonary embolism (PE) to capture the clinical characteristics and outcomes of patients with confirmed COVID-19 and PE.
Milan Report Shows “Urgent Need” to Improve Diagnostics and Study Prophylaxis for VTE in Ambulatory COVID-19 Patients
April 23, 2020—Corrado Lodigiani, MD, et al reported findings of venous and arterial thromboembolic complications in patients with the novel coronavirus (COVID-19) who were admitted to an academic hospital in Milan, Italy.
ACC Outlines Implications and Considerations for Thrombotic Disease Patients During COVID-19 Pandemic
April 17, 2020—The American College of Cardiology (ACC) announced the publication of a review paper delineating the implications of the COVID-19 pandemic in the prevention and management of patients with thrombotic and thromboembolic disease.
2020 Update Published for the CEAP Classification System and Reporting Standards for Chronic Venous Disorders
April 20, 2020—The 2020 update of the CEAP (Clinical-Etiology-Anatomy-Pathophysiology) classification system and reporting standards has been published by Fedor Lurie, MD, et al in Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL; 2020;8:342–352).
AVF Issues White Paper on Considerations in Prophylaxis and Treatment of VTE in COVID-19 Patients
April 17, 2020—The COVID-19 subcommittee of the American Venous Forum (AVF) has produced a white paper on the considerations in prophylaxis and treatment of venous thromboembolism (VTE) in COVID-19 patients.
American College of Surgeons Releases Clinical Guidance for Elective Surgical Case Triage During COVID-19 Outbreak
March 25, 2020—The American College of Surgeons (ACS) announced continued guidance for surgeons to curtail recommendations for elective surgical procedures to preserve the necessary resources for care of critically ill patients during the COVID-19 pandemic.
Vascular Society of Great Britain and Ireland Provides Guidelines for Managing Treatment Amid COVID-19 Pandemic
March 20, 2020—Professor Chris Imray, MD, President of the Vascular Society of Great Britain and Ireland, announced guidelines from the society to address the rapidly evolving situation regarding the COVID-19 virus as it impacts patients and the particular challenges for health care workers.
Study Compares Outcomes of Varicose Vein Treatments
March 18, 2020—Findings from a randomized clinical trial comparing endovenous laser ablation (EVLA) versus mechanochemical ablation (MOCA) in the treatment of primary varicose veins were published by Ahmed M. Tawfik, MD, et al in Journal of Vascular Surgery: Venous and Lymphatic Disorders (JVS-VL; 2020;8:211–215).
Prevalence and Predictors of Elevated Central Venous Pressure and Obstructive Sleep Apnea Evaluated in Patients With Lower Extremity Chronic Venous Disease
March 10, 2020—Online in Journal of Vascular Surgery: Venous & Lymphatic Disorders (JVS-VL) , Raghu Kolluri, MD, et al published findings from a study of the prevalence and predictors of elevated central venous pressure (CVP) and obstructive sleep apnea (OSA) in patients with lower extremity chronic venous disease (CVD).
Sponsored by LimFlow, Inc.
Duplex Ultrasound Technical Considerations for Lower Extremity Venous Disease
Imaging protocols and documentation requirements, key concepts for consideration, and a step-by-step protocol for process standardization.
By Joseph A. Zygmunt Jr, RVT, RPhS; Jan M. Sloves, RVT, RCS, FASE; and Jose I. Almeida, MD, FACS, RPVI, RVT
Sponsored by Inari Medical
Reversing the Miniaturization Trend: Why Going Bigger Is Better for Treating VTE
Design concept and case experiences—how the large-bore Triever24 catheter can extract large volumes of venous clot to optimize procedural success in different VTE settings.
With Christopher M. Huff, MD, FACC, RPVI; Michael A. Jolly, MD, FACC, RPVI; Mitchell J. Silver, DO, FACC, FSVM, RPVI; Venkat P. Tummala, MD; and Eric Trestman, MD
Hot Topics in Venous and Lymphatic Disease
Dr. Neil Khilnani moderates an expert panel discussion on appropriate use in superficial venous care and the emergence of phlebolymphedema management in venous practices.
Panelists: Kathleen Ozsvath, MD; Kathleen Gibson, MD; Elna Masuda, MD; Gloria M. Salazar, MD; Margaret Mann, MD; Fedor Lurie, MD, PhD, RPVI, RVT; Ronald S. Winokur, MD, FSIR, RPVI; Thomas S. Maldonado, MD, FACS; Evgeny Shaydakov, MD, PhD, FRSM; and Antonios P. Gasparis, MD
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available vascular interventional devices in Europe.